American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

Biomarker Technologies for Cardiovascular Health

by admin August 6, 2024
August 6, 2024
Biomarker Technologies for Cardiovascular Health

Cardiex Limited (ASX:CDX) (the “Company”) is pleased to present its investor presentation.

June 2024 Quarterly Highlights

Record annual company revenues – $12.4m.

Initial Pulse units arrived in USA & Australia.Marketing and demand generation campaigns driving awareness and demand.New partnerships and pilot programs.Initial Pulse production run increased to 8,000 (previously 3,000). Pre-submission phase for OTC FDA-clearance for the Pulse. New patent awarded by USPTO for wearable PPG sensor technology.Nearing completion of our wearable sensor validation study.FDA submission for wearable technology anticipated Q1 25.

Financial Overview (Q4 ending 30 June 2024)

Revenue and other income for FY24 of $12.4m (FY23 – $6.0m)Q4 operating cash outflows of $2.8m, being a significant reduction to the Q3 normalized operating outflows of $3.4m, due to:Higher cash receipts of $0.9m in Q4 vs $0.7m in Q3, andFY23 R&D tax incentive of $0.7m.Cash resources and reserves ~ $6.5m, comprising:$0.5m cash; and$6.0m being funded under the Funding Commitment Agreement with C2 Ventures.Cash resources are believed to be sufficient to fund the Company’s growth initiatives, its operations, and to meet its business objectives.

Click here for the full ASX Release

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Assays up to 63g/t Gold and 3.2% Copper Highlight Immense Exploration Upside
next post
Geophysics and Drilling Discovers New Mineralised Structure West of Horden Lake, further Potential along Strike.

Related Posts

BT Group share price hits key level: can...

March 19, 2025

Dogecoin, Shiba Inu consolidates at key prices as...

April 28, 2025

Additional Deeper Targets Identified in Bonito Prospect

April 3, 2024

USD/BRL: Why the Brazilian real crashed—and may rebound

July 10, 2025

These SPY ETF stocks are driving S&P 500...

January 24, 2025

What next for the soaring Rolls-Royce share price?

December 9, 2024

Remitly stock has multiple catalysts and could surge...

October 20, 2024

DXY index forecast ahead of key central bank...

January 28, 2025

Hang Seng index forms a bullish pattern after...

January 18, 2025

Here’s why Sui price is in an ‘unstoppable’...

September 18, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • How Donald Trump’s immigration crackdown may tank the labor market

      August 4, 2025
    • Trump’s tariff threat looms over India’s Russian oil deals

      August 4, 2025
    • Trump moves nuclear submarines near Russia: what triggered the move and what’s ahead

      August 3, 2025
    • BOE rate cuts offer little relief as UK households face mounting financial strain

      August 3, 2025
    • Retail investors shift focus to Europe as US valuations stretch

      August 3, 2025

    Categories

    • Business (3,583)
    • Investing (2,703)
    • Latest News (2,031)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved